Taken together, the studies of CD8+ T cells in anti-tumor responses support the possibility of generating bona fide tumor-specific memory particularly in the context of localized tumors and as a consequence of vaccination strategies with tumor-specific epitopes that can be generated by cancers with frequent mutations. The gene discussed is CD8A; the disease is cancer.